Contact
searchSearch
HMP Global
Quiz

Hyperuricemia vs Gout: Understanding the Clinical Relationship

Riya Gandhi, MA
04/01/2026
© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Rheumatology & Arthritis Learning Network or HMP Global, its employees, and affiliates.

Related Content

Quiz
Treat-to-Target vs Symptom-Based Gout Care: What’s the Difference?
04/01/2026
Riya Gandhi, MA
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout...
04/01/2026
Rheumatology & Arthritis
Quiz
Why Flare Frequency Matters in Clinical Trials
04/01/2026
Riya Gandhi, MA
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency...
04/01/2026
Rheumatology & Arthritis
Quiz
Pegloticase + Methotrexate: What Rising Uric Acid Means
04/01/2026
Riya Gandhi, MA
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of...
04/01/2026
Rheumatology & Arthritis
Clinical Trials
Shorter Pegloticase Infusions Maintain Safety and Efficacy in Uncontrolled Gout
03/18/2026
Jessica Garlewicz
For practicing rheumatologists, the key takeaway is that a 60-minute infusion may offer a more practical option without compromising outcomes.
For practicing rheumatologists, the key takeaway is that a 60-minute infusion may offer a more practical option without compromising outcomes.
For practicing rheumatologists,...
03/18/2026
Rheumatology & Arthritis

Popular Articles

News
Bone Loss in Axial Spondyloarthritis Key to Effective Management Strategies
05/10/2024

Jessica Garlewicz, Digital Managing Editor

Jessica Garlewicz, Digital Managing E...
Multifaceted contributors to bone loss in axial spondyloarthritis requires early detection and a multidisciplinary approach .
Multifaceted contributors to bone loss in axial spondyloarthritis requires early detection and a multidisciplinary approach .
Multifaceted contributors to...
05/10/2024
Rheumatology & Arthritis
News
Regional Differences Found in Phenotypes of Patients With axSpA
09/20/2024
Jolynn Tumolo
Investigators suggest this information can help reduce delays in diagnosis and treatment.
Investigators suggest this information can help reduce delays in diagnosis and treatment.
Investigators suggest this...
09/20/2024
Rheumatology & Arthritis
News
Patients With nr-axSpA and r-axSpA Show Differences in Several Key Criteria
06/24/2024
Rebecca Mashaw
Researchers found distinct variations between patients with nonradiographic and radiographic axial spondyloarthritis in age of disease onset, sex, and other factors.
Researchers found distinct variations between patients with nonradiographic and radiographic axial spondyloarthritis in age of disease onset, sex, and other factors.
Researchers found distinct...
06/24/2024
Rheumatology & Arthritis
News
Risk of Cardiovascular Disease May be Easing in Patients With PsA
11/08/2024
Rebecca Mashaw
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower...
11/08/2024
Rheumatology & Arthritis
Misti Paudel
Podcast
Misti Paudel, PhD, on Difficult-to-Treat Rheumatoid Arthritis
08/12/2024
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she...
08/12/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use